Not applicableStudy completedNCT05734053
What this trial is testing
Nilotinib for Patients With Chronic Myeloid Leukemia in First Line and Any Subsequent Line
Who this might be right for
Chronic Myeloid Leukemia
Novartis Pharmaceuticals 222
Showing 20 of 0 results